All Resources
Our resource hub to discover reports, policy papers and other forms of informative content
Filter by
The Canadian Research and Development Pharmaceutical Sector, 2021
…economy in 2021. It builds on the annual reports produced since 2018, sponsored by Innovative Medicines Canada (IMC), an industry association representing patented medicine enterprises in Canada’s R&D pharmaceutical sector….
The Suspension and Reformulation of the PMPRB Guidelines is Urgently Required: IMC Response to PMPRB 2022 Guidelines Proposals
Innovative Medicines Canada has submitted formal feedback to the Patented Medicine Prices Review Board’s (PMPRB) revised Draft Guidelines public consultation, calling for a suspension of the planned implementation to ensure…
